Clearside Biomedical: Funding, Investors & Team (Oct 2026)
Clearside BioMedical, an ophthalmic company, specializes in the research, development, and commercialization of therapeutic products through an ocular microinjection platform that targets the individual compartments of the eye. It provides a non-surgical application for dosing drugs to distinct eye tissues, such as the retina, trabecular meshwork, and corneal stroma. The company’s CLS1001 is under development for retinal applications through the delivery of therapeutics to the suprachoroidal space. Clearside BioMedical was incorporated in 2011 and is based in Atlanta, Georgia.
Clearside Biomedical has raised $65.0M across 1 funding round on record, the most recent a Post-IPO Debt of $65.0M announced in Aug 2022.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Clearside Biomedical Company Profile and Key Stats
Latest funding round on record: Aug 2022.
Clearside Biomedical Funding Rounds
Clearside Biomedical Founders and Leadership Team
Contact details for the Clearside Biomedical team: 1 of 1 has an email address on file.
Start 14-day free trial →Clearside Biomedical Funding Compared to Other Biotechnology Startups
Clearside Biomedical's latest round of $65.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Clearside Biomedical in Biotechnology and Alpharetta
Companies Similar to Clearside Biomedical
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Clearside Biomedical Funding FAQs
What does Clearside Biomedical do?
Clearside BioMedical, an ophthalmic company, specializes in the research, development, and commercialization of therapeutic products through an ocular microinjection platform that targets the individual compartments of the eye. It provides a non-surgical application for dosing drugs to distinct eye tissues, such as the retina, trabecular meshwork, and corneal stroma. The company’s CLS1001 is under development for retinal applications through the delivery of therapeutics to the suprachoroidal space. Clearside BioMedical was incorporated in 2011 and is based in Atlanta, Georgia.
How much funding has Clearside Biomedical raised?
Clearside Biomedical has raised $65.0M across 1 round on record. The most recent is a Post-IPO Debt of $65.0M announced in Aug 2022.
When did Clearside Biomedical last raise funding?
Clearside Biomedical's most recent funding round on record is a Post-IPO Debt of $65.0M, announced in Aug 2022.
Who is the CEO of Clearside Biomedical?
George Lasezkay is listed as CEO at Clearside Biomedical.
Where is Clearside Biomedical headquartered?
Clearside Biomedical is based in Alpharetta, Georgia, United States.
How many employees does Clearside Biomedical have?
Clearside Biomedical is in the 11-50 employee band.
How does Clearside Biomedical's funding compare to other Biotechnology startups?
Clearside Biomedical's latest round of $65.0M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Clearside Biomedical Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Clearside Biomedical is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.